<ARTICLE>                     5
<CIK>                         0000880771
<NAME>                        SCICLONE PHARMACEUTICALS, INC.
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   MAR-31-1997
<CASH>                                          3,458,100
<SECURITIES>                                   27,347,625
<RECEIVABLES>                                   3,522,140
<ALLOWANCES>                                            0
<INVENTORY>                                     2,531,091
<CURRENT-ASSETS>                               14,354,120
<PP&E>                                            939,466
<DEPRECIATION>                                   (638,495)
<TOTAL-ASSETS>                                 38,928,835
<CURRENT-LIABILITIES>                           4,498,018
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                      109,186,964
<OTHER-SE>                                    (74,756,147)
<TOTAL-LIABILITY-AND-EQUITY>                   38,928,835
<SALES>                                           670,538
<TOTAL-REVENUES>                                  670,538
<CGS>                                             261,565
<TOTAL-COSTS>                                     261,565
<OTHER-EXPENSES>                                3,961,898
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                      0
<INCOME-PRETAX>                                (3,040,170)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                            (3,040,170)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (3,040,170)
<EPS-PRIMARY>                                       (0.17)
<EPS-DILUTED>                                           0